6.3 Advanced Wound Modalities: Negative Pressure Wound Therapy and Cellular/Tissue-Based Products

Negative Pressure Wound Therapy: Biophysical Mechanisms

Negative Pressure Wound Therapy (NPWT), historically recognized as Vacuum-Assisted Closure (V.A.C.), is an advanced biophysical modality that applies controlled subatmospheric pressure to a wound bed through a sealed, reticulated open-pore interface. Pioneered clinically by Argenta and Morykwas in 1997, NPWT has revolutionized surgical limb salvage in diabetic foot complications. The physiological benefits of NPWT operate through two foundational mechanical phenomena: macro-strain and micro-strain.

+-------------------------------------------------------------------------+
|                   BIOPHYSICAL FOUNDATIONS OF NPWT                       |
+------------------------------------+------------------------------------+
| MACRO-STRAIN (Gross Tissue Scale)  | MICRO-STRAIN (Cellular Scale)      |
+------------------------------------+------------------------------------+
| - Centripetal mechanical draw      | - Micro-deformation at pore struts |
| - Pulls wound margins together     | - Mechanotransduction via integrins|
| - Collapses dead space & cavities  | - Opens stretch-activated channels |
| - Continuous fluid evacuation      | - Triggers ERK/MAPK phosphorylation|
| - Relieves interstitial edema      | - Stimulates DNA synthesis/mitosis |
| - Decompresses capillary loops     | - Spikes VEGF & neo-angiogenesis   |
+------------------------------------+------------------------------------+

1. Macro-Strain (Tissue-Level Mechanics)

Macro-strain represents the visible physical response of the tissue to subatmospheric suction:

• Centripetal Wound Contraction: Negative pressure creates physical tension that pulls the wound edges inward toward the center of the dressing sponge, visibly reducing wound dimensions, surface area, and volume.
• Dead-Space Collapse: In deep cavitary wounds or post-amputation flaps (e.g., following transmetatarsal amputation), negative pressure eliminates undermining and dead-space pockets, preventing hematoma and seroma accumulation.
• Interstitial Decompression and Edema Evacuation: Diabetic tissue surrounding acute surgical wounds is typically flooded with interstitial edema. Excessive interstitial fluid creates hydraulic pressure that compresses low-pressure capillary venules and lymphatics. NPWT continuously evacuates excess interstitial fluid, decompressing capillary beds and restoring functional microvascular blood flow and tissue oxygenation.
• Soluble Factor Clearance: Suction continuously removes wound drainage loaded with destructive matrix metalloproteinases, pro-inflammatory cytokines, and planktonic bacteria.

2. Micro-Strain (Cellular-Level Mechanobiology)

Micro-strain represents the microscopic, cellular deformation occurring where open-pore foam struts contact the biological tissue bed:

• Mechanotransduction: The pores of the foam (typically 400 to 600 micrometers in polyurethane foam) physically trap and pinch individual cell clusters. Under -125 mmHg subatmospheric pressure, cell membranes and cytoskeletons undergo micro-mechanical stretching.
• Intracellular Signaling Cascades: Mechanical membrane deformation activates stretch-activated cation channels and clusters cell-surface integrins. This triggers intracellular phosphorylation cascades, including the mitogen-activated protein kinase (MAPK) and extracellular signal-regulated kinase (ERK) pathways.
• Mitosis and Angiogenesis: Activated cells upregulate gene transcription for structural proteins, cyclins, and vascular growth factors—most notably Vascular Endothelial Growth Factor (VEGF) and Fibroblast Growth Factor 2 (FGF-2). The clinical result is an explosion of thick, robust, highly vascularized granulation tissue forming at rates two to three times faster than conventional passive moist dressings.

---

Clinical Indications and Operational Parameters of NPWT

Primary Clinical Indications in Diabetic Limb Salvage

1. Post-Operative Surgical Debridement Wounds: Extensive defects following incision and drainage or fasciotomy for deep plantar space abscesses or necrotizing soft-tissue infections.
2. Partial Foot Amputations: High-risk amputations, including transmetatarsal amputations (TMA), ray resections, and partial calcanectomies, where large subcutaneous voids and vulnerable surgical flaps require rapid stabilization and granulation coverage.
3. Wagner Grade 2 and 3 Ulcers: Deep neuropathic ulcers penetrating down to tendon, joint capsule, or deep fascia with clean margins and adequate baseline vascularity.
4. Split-Thickness Skin Graft (STSG) Bolstering: Securing and immobilizing cutaneous autografts or cellular dermal scaffolds, preventing shear forces, eliminating fluid hematomas beneath the graft, and promoting rapid graft inosculation and revascularization.

Operational Parameters and Foam Interface Selection

+-------------------------------------------------------------------------+
|               NPWT FOAM INTERFACE CHARACTERISTICS                       |
+-----------------------+-------------------------------------------------+
| POLYURETHANE (PU)     | - Reticulated open-pore (400–600 μm), black     |
| FOAM                  | - Rapid granulation formation; high fluid draw  |
|                       | - Primary choice for deep cavitary defects      |
+-----------------------+-------------------------------------------------+
| POLYVINYL ALCOHOL     | - Dense, fine-pore, pre-hydrated, white         |
| (PVA) FOAM            | - Non-adherent, high tensile strength           |
|                       | - Placed over exposed tendon, bone, or nerve    |
+-----------------------+-------------------------------------------------+

• Standard Pressure Setting: The universally accepted clinical standard for chronic and post-operative diabetic wounds is -125 mmHg of continuous subatmospheric pressure. Landmark porcine laser Doppler flow studies by Morykwas demonstrated that blood flow peaks at -125 mmHg (increasing local microvascular perfusion up to 4-fold); pressures exceeding -200 mmHg induce capillary occlusion and tissue ischemia.
• Continuous vs. Intermittent Mode:
  • Continuous Mode: Recommended for the initial 48 hours post-operatively, in patients experiencing discomfort, around fresh skin grafts or flap reconstructions, and in wounds producing copious exudate.
  • Intermittent Mode (e.g., 5 minutes on, 2 minutes off): Maximizes cellular micro-strain by repeatedly deforming cell membranes, inducing even faster rates of granulation tissue proliferation. However, it can cause localized pain during pressure cycling and is contraindicated if dressing seal integrity is difficult to maintain.
• Foam Interfaces:
  • Polyurethane (PU) Black Foam: Hydrophobic, open-pore (400 to 600 μm pores) reticulated foam. Maximizes fluid transport and creates strong micro-strain, stimulating robust granulation. Should never be placed in direct contact with exposed bare tendons or neurovascular bundles, as granulation tissue rapidly grows into the foam pores, causing severe pain and avulsive tissue tearing during dressing changes.
  • Polyvinyl Alcohol (PVA) White Foam: Hydrophilic, dense, pre-moistened, small-pore foam with high tensile strength. It is non-adherent and restricts tissue ingrowth. It is mandatory as a protective contact layer over exposed tendons, periosteum, nerves, or inside narrow tunneled tracts.
• Dressing Change Intervals: Standard NPWT dressings are changed every 48 to 72 hours under sterile conditions. In the presence of high residual bioburden, dressings may require changing every 24 hours.

---

Contraindications and Safety Protocols for NPWT

NPWT is a powerful modality that carries severe risks if deployed inappropriately:

1. Uncontrolled Deep Infection or Necrotic Bone: NPWT is not a substitute for drainage, debridement, or antimicrobial treatment. Establish an infection source-control plan before using it over a postsurgical wound; osteomyelitis management does not always require complete bone resection.
2. Exposed Major Blood Vessels, Vascular Grafts, or Organs: NPWT foam placed directly over exposed arteries, veins, or synthetic vascular bypass grafts (e.g., femoral-popliteal bypass) can erode vascular walls via direct suction and mechanical abrasion, precipitating catastrophic exsanguination. If NPWT is applied near vital vessels, a thick, protective biological barrier (viable muscle flap, heavy biological matrix, or multiple non-adherent silicone contact layers) must completely isolate the vessel from the foam.
3. Active Malignancy in the Wound Bed: Applying strong cellular mitotic and angiogenic stimuli to an undiagnosed Marjolin's ulcer (squamous cell carcinoma) or neoplastic tissue accelerates tumor growth and metastasis.
4. Necrotic Tissue with Dry Eschar: NPWT is not an active debriding modality for thick, hardened eschar. Eschar prevents transmission of subatmospheric pressure to the bed; nonviable tissue must be debrided first.
5. Unexplored or Non-Enteric Fistulae: Applying suction to unprobed sinus tracts communicating with body cavities can cause severe internal organ damage.

---

Current Evidence Boundary

IWGDF recommends considering NPWT as an adjunct for postsurgical diabetic foot wounds and recommends against using it for a nonsurgical diabetic foot ulcer solely to improve healing. Pressure settings and interfaces are individualized rather than universally fixed at -125 mmHg. For products, current guidance does not recommend routine cellular or acellular skin substitutes; selected placental-derived products or an autologous leukocyte/platelet/fibrin patch may be considered after good standard care fails and resources, patient preferences, perfusion, infection control, and offloading are addressed.

Cellular and Tissue-Based Products (CTPs) / Skin Substitutes

When a diabetic foot ulcer fails to close despite optimal standard wound management, clinicians escalate to Cellular and Tissue-Based Products (CTPs)—often referred to clinically as "skin substitutes" or biologics. CTPs supply structural extracellular matrix scaffolds, viable cells, and essential signaling molecules to stimulate host cellular repopulation and tissue regeneration.

+-------------------------------------------------------------------------+
|                   BIOLOGICAL TAXONOMY OF ADVANCED CTPs                  |
+-------------------------------------------------------------------------+
| HUMAN ACELLULAR DERMAL MATRICES (hADMs)                                 |
|   - Cadaveric human dermis decellularized to yield structural ECM       |
|   - Preserves Type I/III collagen, elastin, basement vascular channels  |
|   - Examples: GraftJacket, DermACELL                                    |
+-------------------------------------------------------------------------+
| HUMAN PLACENTAL MEMBRANES (dHACM / Amniotic Allografts)                 |
|   - Donated post-cesarean amniotic / chorionic sac allograft            |
|   - Reservoir of PDGF, VEGF, bFGF, EGF, and anti-inflammatory TIMPs     |
|   - Examples: EpiFix, AmnioBand                                         |
+-------------------------------------------------------------------------+
| BIOENGINEERED LIVING CELLULAR CONSTRUCTS                                |
|   - Living cultured neonatal foreskin fibroblasts & keratinocytes       |
|   - Active cytokine synthesis; physiological cellular cross-talk        |
|   - Examples: Apligraf (bilayered), Dermagraft (fibroblast mesh)        |
+-------------------------------------------------------------------------+

Biological Classification of CTPs

1. Human Acellular Dermal Matrices (hADMs):
   • Composition: Harvested from donated human cadaveric skin and subjected to chemical or enzymatic decellularization processes that eliminate all cellular components and major histocompatibility complex (MHC) surface antigens to prevent host immune rejection.
   • Structural Integrity: Preserves the natural, three-dimensional collagenous architecture, intact elastic fibers, fibronectin, proteoglycans, and pre-existing vascular channels of the native dermis.
   • Mechanism: Acts as an acellular architectural scaffold. Host endothelial cells and fibroblasts migrate into the matrix channels, revascularizing and recellularizing the graft to build a new autologous neodermis.
2. Human Placental Membranes (Amnion / Chorion Allografts):
   • Composition: Harvested from the placenta of consented mothers following scheduled elective Cesarean sections; available as dehydrated human amnion/chorion membrane (dHACM) or cryopreserved allografts.
   • Bioactive Content: Naturally enriched with a dense physiological cocktail of structural proteins and concentrated signaling cytokines, including PDGF-AA, PDGF-BB, VEGF, bFGF, EGF, TGF-β1, and Tissue Inhibitors of Metalloproteinases (TIMP-1, TIMP-2).
   • Clinical Action: Promotes host stem cell recruitment, dampens chronic inflammation, downregulates local MMP activity, suppresses scar formation, and accelerates re-epithelialization.
3. Bioengineered Living Cellular Constructs:
   • Bilayered Cellular Construct (e.g., Apligraf): Comprises a bovine Type I collagen sponge populated with living human neonatal dermal fibroblasts, surfaced with a stratified layer of living neonatal epidermal keratinocytes. It mimics human skin architecture and functions as an active "bio-factory," continuously producing physiological cascades of growth factors, interleukins, and extracellular matrix proteins.
   • Dermal Cellular Construct (e.g., Dermagraft): Living human neonatal fibroblasts cryopreserved onto a bioabsorbable polyglactin-910 mesh scaffold. Once thawed and applied, the metabolically active fibroblasts synthesize human collagen, fibronectin, tenascin, and cytokines.

---

Four-Week Trajectory as a Reassessment Point

CTPs are costly advanced therapies that must be deployed based on validated clinical algorithms rather than haphazard trial-and-error.

The 4-Week 50% Reduction Metric (Sheehan et al.)

In a seminal multi-center prospective trial published by Sheehan et al. (2003), diabetic foot ulcers were evaluated after 4 weeks of standard optimal care (sharp debridement, pressure offloading, moisture-balanced dressings, infection management):

• Interpretation: Four-week area change is a useful prognostic signal, not a deterministic rule. A favorable trajectory supports continuing effective care; a poor trajectory triggers reassessment of perfusion, infection, pressure, wound care, systemic barriers, and adherence before any adjunct is chosen.